1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsMRC Proof of Concept: stage one is sponsored by Medical Research Council (MRC) / UKRI. Funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions, including biomarker validation and development of clinical decision-making tools.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Medical Research Council (MRC) – UKRI Medical Research Council (MRC) MRC funds world-leading discovery and translational research to accelerate diagnosis, advance treatment and prevent human illness.
Funding, assessment and award management Strategy, remit and programmes People, skills and fellowships Innovation and collaboration Investments, impacts and engagement Institutes, facilities and resources Video: we are the Medical Research Council AI tool reveals hidden organ damage caused by high blood pressure How cells fight infection from the inside From MRC discovery research to a one-minute cancer treatment Men Minds: young men making time for young men From ward rounds to speech sounds: an MRC Clinical Fellow’s story UKRI Translation: MRC Proof of Concept: stage one This funding opportunity was previously titled ‘Developmental pathway funding scheme: stage one’.
Apply for funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions. You must be employed at a research organisation eligible for Medical Research Council (MRC) funding.
Medical Research Council (MRC) 2 July 2026 9:00am UK time 18 November 2026 4:00pm UK time Pre-announcement: UK Obesity Research Institute Apply for funding to establish a UK Obesity Research Institute, undertaking world-leading research into the mechanistic biomedical drivers of obesity and develop targeted interventions to prevent and treat obesity and its health consequences.
Applications must be led by a UK-based research organisation eligible for MRC funding.
Medical Research Council (MRC) 30 July 2026 9:00am UK time 19 November 2026 4:00pm UK time View all MRC opportunities Medical Research Council (MRC) Funding, assessment and award management Strategy, remit and programmes People, skills and fellowships Innovation and collaboration Investments, impacts and engagement Institutes, facilities and resources Keep up to date with funding, news and events, and a weekly newsletter.
MRC ES seminar: embedding sustainability into research Online and at University of Oxford, The Life and Mind building (lecture theatre 1), South Parks Road, Oxford, OX1 3EL This is the website for UKRI: our seven research councils, Research England and Innovate UK. Let us know if you have feedback or would like to help improve our online products and services .
According to the current listing, eligibility includes: Applicants must be employed at a UK research organisation eligible for MRC funding and demonstrate they will direct and be actively engaged in the project. Confirm the full requirements in the official notice before applying.
MRC Proof of Concept: stage one is funded by Medical Research Council (MRC) / UKRI. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleDARPA BTO pre-released four FY26 SBIR/STTR topics on April 30, 2026, with proposals due June 3. Two topics — SWiFT and EXPOSITION — offer Direct-to-Phase-II awards up to $1.5M, bypassing the standard Phase I gate. Here is what each topic is actually solving, why the DP2 structure matters, and how small biotech, surgical robotics, and battlefield-medicine teams should decide whether to compete.
Read articleOn June 3, 2026, four DARPA Biological Technologies Office SBIR topics close simultaneously — SWiFT, BARK, EXPOSITION, and Medical Swarm Robotics. Combined Phase I plus Phase II potential exceeds $6 million per company, and together they sketch a coherent strategy of distributed, autonomous, dual-species combat casualty care that depends on small businesses, not primes, to actually build.
Read article